First-line ribociclib and endocrine therapy may be more effective than combined chemotherapy in aggressive breast cancer

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainIn patients with hormone receptor-positive, HER2-negative, advanced breast cancer—including patients with visceral cris

Updated on: February 01,2024

First-line ribociclib and endocrine therapy may be more effective than combined chemotherapy in aggressive breast cancer

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainIn patients with hormone receptor-positive, HER2-negative, advanced breast cancer—including patients with visceral cris

Updated on:February 01,2024

Trial: Standard chemoradiation superior to de-intensification approaches for HPV-related oropharyngeal cancer

byAmerican Society for Radiation OncologyCredit: Unsplash/CC0 Public DomainResearchers looking to de-intensify radiation treatments for people with early-stage, HPV-associated oropharyngeal canc

Updated on: October 22,2024

Trial: Standard chemoradiation superior to de-intensification approaches for HPV-related oropharyngeal cancer

byAmerican Society for Radiation OncologyCredit: Unsplash/CC0 Public DomainResearchers looking to de-intensify radiation treatments for people with early-stage, HPV-associated oropharyngeal canc

Updated on:October 22,2024

Discovery of new mechanism explains how ovarian cancer disables immune cells

byWeill Cornell Medical CollegeThis confocal micrograph shows two proteins,TAGLN2 (green) and FABP5 (red), are found together (yellow) on the surfaces of T cells, enabling the cells to pick up l

Updated on: November 11,2024

Discovery of new mechanism explains how ovarian cancer disables immune cells

byWeill Cornell Medical CollegeThis confocal micrograph shows two proteins,TAGLN2 (green) and FABP5 (red), are found together (yellow) on the surfaces of T cells, enabling the cells to pick up l

Updated on:November 11,2024

Researchers complete largest genomic analysis of Merkel cell carcinoma patients

by H. Lee Moffitt Cancer Center & Research InstituteCredit: CC0 Public DomainMerkel cell carcinoma (MCC) is a rare, aggressive skin tumor that is diagnosed in approximately 2,000 people each

Updated on: June 04,2024

Researchers complete largest genomic analysis of Merkel cell carcinoma patients

by H. Lee Moffitt Cancer Center & Research InstituteCredit: CC0 Public DomainMerkel cell carcinoma (MCC) is a rare, aggressive skin tumor that is diagnosed in approximately 2,000 people each

Updated on:June 04,2024

Deep learning approach enhances HER2 scoring in breast cancer

byUCLA Engineering Institute for Technology AdvancementAutomated HER2 Scoring in Breast Cancer Images Using Deep Learning and Pyramid Sampling. Credit: UCLA Engineering Institute for Technology

Updated on: August 01,2024

Deep learning approach enhances HER2 scoring in breast cancer

byUCLA Engineering Institute for Technology AdvancementAutomated HER2 Scoring in Breast Cancer Images Using Deep Learning and Pyramid Sampling. Credit: UCLA Engineering Institute for Technology

Updated on:August 01,2024

New test predicts chance of living more than a year on targeted breast cancer treatment

by Institute of Cancer ResearchBreast cancer cells stained for DNA (red), NFkB (green), and a reactive oxygen species probe (blue). Credit: Julia Sero / the ICR, 2011A new test could pick out wom

Updated on: May 23,2024

New test predicts chance of living more than a year on targeted breast cancer treatment

by Institute of Cancer ResearchBreast cancer cells stained for DNA (red), NFkB (green), and a reactive oxygen species probe (blue). Credit: Julia Sero / the ICR, 2011A new test could pick out wom

Updated on:May 23,2024

A new therapeutic target for metastatic and resistant prostate cancers

by IDIBELL-Bellvitge Biomedical Research InstituteÁlvaro Aytés & Katia Ruggero. Credit: IDIBELLProstate Cancer researchers from the Bellvitge Biomedical Research Institute (IDIBELL), led by D

Updated on: April 01,2024

A new therapeutic target for metastatic and resistant prostate cancers

by IDIBELL-Bellvitge Biomedical Research InstituteÁlvaro Aytés & Katia Ruggero. Credit: IDIBELLProstate Cancer researchers from the Bellvitge Biomedical Research Institute (IDIBELL), led by D

Updated on:April 01,2024

Digital rectal examination is not useful to early detect prostate cancers, says new research

by European Association of UrologyCredit: Unsplash/CC0 Public DomainA common method of detecting prostate cancer may not be accurate enough as a reliable screening tool by itself, scientists have

Updated on: January 30,2024

Digital rectal examination is not useful to early detect prostate cancers, says new research

by European Association of UrologyCredit: Unsplash/CC0 Public DomainA common method of detecting prostate cancer may not be accurate enough as a reliable screening tool by itself, scientists have

Updated on:January 30,2024

New study shows association of historical housing discrimination and shortfalls in colon cancer treatment

by Jeff Hansen,University of Alabama at BirminghamMap of redlining in Birmingham, 1933. Credit: Public domain, Wikimedia CommonsA nationwide study of 196 cities shows that housing discrimination

Updated on: March 30,2024

New study shows association of historical housing discrimination and shortfalls in colon cancer treatment

by Jeff Hansen,University of Alabama at BirminghamMap of redlining in Birmingham, 1933. Credit: Public domain, Wikimedia CommonsA nationwide study of 196 cities shows that housing discrimination

Updated on:March 30,2024

Researchers identify markers of chemotherapy resistance and outcome in triple negative breast cancer

by Molly Chiu,Baylor College of MedicineCredit: Unsplash/CC0 Public DomainResearchers at Baylor College of Medicine and the Broad Institute of MIT and Harvard and clinicians at Washington Univer

Updated on: February 01,2024

Researchers identify markers of chemotherapy resistance and outcome in triple negative breast cancer

by Molly Chiu,Baylor College of MedicineCredit: Unsplash/CC0 Public DomainResearchers at Baylor College of Medicine and the Broad Institute of MIT and Harvard and clinicians at Washington Univer

Updated on:February 01,2024

Can some cancer patients safely skip radiation therapy? New studies say yes

by Dennis ThompsonRadiation therapy might not be necessary in treating some forms of rectal cancer and lymphoma, sparing patients from the toxic treatment, a pair of new clinical trials shows.One tria

Updated on: February 01,2024

Can some cancer patients safely skip radiation therapy? New studies say yes

by Dennis ThompsonRadiation therapy might not be necessary in treating some forms of rectal cancer and lymphoma, sparing patients from the toxic treatment, a pair of new clinical trials shows.One tria

Updated on:February 01,2024

Scientists find core regulatory circuit controlling identity of aggressive leukemia

bySt. Jude Children's Research HospitalCo-corresponding author Brian J. Abraham, PhD, and co-author Kelsey Maher, PhD. Credit: St. Jude Children's Research HospitalA collaboration betwee

Updated on: March 30,2024

Scientists find core regulatory circuit controlling identity of aggressive leukemia

bySt. Jude Children's Research HospitalCo-corresponding author Brian J. Abraham, PhD, and co-author Kelsey Maher, PhD. Credit: St. Jude Children's Research HospitalA collaboration betwee

Updated on:March 30,2024